Age-dependent progression from clearance to vulnerability in the early response of periventricular microglia to α-synuclein toxic species.

Cytoplasmic alpha-synuclein (αSyn) aggregates are a typical feature of Parkinson's disease (PD). Extracellular insoluble αSyn can induce pathology in healthy neurons suggesting that PD neurodegeneration may spread through cell-to-cell transfer of αSyn proteopathic seeds. Early pro-homeostatic reaction of microglia to toxic forms of αSyn remains elusive, which is especially relevant considering the recently uncovered microglial molecular diversity.

Integrated clinico-molecular analysis of gastric cancer in European and Latin American populations: LEGACY project.

Background: Gastric cancer (GC) is recognized for intrinsic heterogeneity, although it is similarly approached in Europe and Latin America (LATAM). The LEGACY project aimed to deepen GC molecular understanding through multi-omics analysis in Europe and LATAM GC samples.

Patients And Methods: Tumor samples were centrally reviewed for histology, human epidermal growth factor receptor 2 (HER2) expression, and mismatch repair-deficient (dMMR)/microsatellite instability (MSI) status.

Predictive microbiology through the last century. From paper to Excel and towards AI.

This chapter provides a historical perspective on predictive microbiology: from its inception till its current state, and including potential future developments. A look back to its origins in the 1920s underlies that scientists at the time had great ideas that could not be developed due to the lack of proper technologies. Indeed, predictive microbiology advancements mostly halted till the 1980s, when computing machines became broadly available, evidencing how these technologies were an enabler of predictive microbiology.

Contrasting the clinical and biological characteristics of young and old COPD patients.

Background: The ECLIPSE study was a large, international, prospective, controlled, observational study that included COPD patients (Global Initiative for Chronic Obstructive Lung Disease (GOLD) grades 2-4), as well as smoking and non-smoking participants with normal spirometry, aged 40-75 years, who were followed-up regularly for 3 years. Here we sought to contrast the clinical and biological characteristics of young COPD controls of similar age and older COPD patients included in ECLIPSE.

Methods: We compared 106 young (<50 years) and 488 old (>70 years) COPD patients, as well as 119 young smokers and 92 nonsmoker controls (<50 years) with normal spirometry.